Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR

23.4  -1.43 (-5.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1BAYN. 1BAYN was compared to 52 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year 1BAYN was profitable.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
Of the past 5 years 1BAYN 4 years had a positive operating cash flow.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B -10B

1.2 Ratios

1BAYN has a Return On Assets of -0.82%. This is comparable to the rest of the industry: 1BAYN outperforms 40.38% of its industry peers.
1BAYN has a Return On Equity (-2.88%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.16%, 1BAYN is doing worse than 61.54% of the companies in the same industry.
1BAYN had an Average Return On Invested Capital over the past 3 years of 7.78%. This is significantly below the industry average of 13.62%.
The 3 year average ROIC (7.78%) for 1BAYN is well above the current ROIC(2.16%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.82%
ROE -2.88%
ROIC 2.16%
ROA(3y)0.54%
ROA(5y)-0.82%
ROE(3y)1.6%
ROE(5y)-4.19%
ROIC(3y)7.78%
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

1.3 Margins

1BAYN's Operating Margin of 4.24% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 61.54% of its industry peers.
The Gross Margin of 1BAYN (57.14%) is worse than 71.15% of its industry peers.
In the last couple of years the Gross Margin of 1BAYN has remained more or less at the same level.
Industry RankSector Rank
OM 4.24%
PM (TTM) N/A
GM 57.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5Y0.14%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
1BAYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B 100B

2.2 Solvency

1BAYN has an Altman-Z score of 0.90. This is a bad value and indicates that 1BAYN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.90, 1BAYN perfoms like the industry average, outperforming 40.38% of the companies in the same industry.
The Debt to FCF ratio of 1BAYN is 7.76, which is on the high side as it means it would take 1BAYN, 7.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.76, 1BAYN is in line with its industry, outperforming 40.38% of the companies in the same industry.
1BAYN has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
1BAYN's Debt to Equity ratio of 1.20 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 7.76
Altman-Z 0.9
ROIC/WACC0.36
WACC5.94%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.32 indicates that 1BAYN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.32, 1BAYN is doing worse than 61.54% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN has a Quick ratio of 0.81. This is in the lower half of the industry: 1BAYN underperforms 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.81
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

More info and screens

2

3. Growth

3.1 Past

1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.41%.
Measured over the past years, 1BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.43% on average per year.
EPS 1Y (TTM)-33.41%
EPS 3Y-13.17%
EPS 5Y-8.43%
EPS Q2Q%-85.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.39%

3.2 Future

Based on estimates for the next years, 1BAYN will show a small growth in Earnings Per Share. The EPS will grow by 5.43% on average per year.
Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.43% on average per year.
EPS Next Y10.52%
EPS Next 2Y9.08%
EPS Next 3Y6.35%
EPS Next 5Y5.43%
Revenue Next Year0.12%
Revenue Next 2Y0.98%
Revenue Next 3Y1.38%
Revenue Next 5Y1.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

1BAYN is valuated cheaply with a Price/Earnings ratio of 5.49.
Based on the Price/Earnings ratio, 1BAYN is valued cheaper than 94.23% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, 1BAYN is valued rather cheaply.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 4.97.
Based on the Price/Forward Earnings ratio, 1BAYN is valued cheaply inside the industry as 96.15% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, 1BAYN is valued rather cheaply.
Industry RankSector Rank
PE 5.49
Fwd PE 4.97
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1BAYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 90.38% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaper than 98.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.33
EV/EBITDA 5.93
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y9.08%
EPS Next 3Y6.35%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.44%, 1BAYN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.86, 1BAYN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, 1BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

The dividend of 1BAYN decreases each year by -2.26%.
Dividend Growth(5Y)-2.26%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-15.11%
EPS Next 2Y9.08%
EPS Next 3Y6.35%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (3/7/2025, 7:00:00 PM)

23.4

-1.43 (-5.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-05 2025-03-05/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners47.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.99B
Analysts67.14
Price Target27.78 (18.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend2.42
Dividend Growth(5Y)-2.26%
DP-15.11%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.42%
Min EPS beat(2)-17.26%
Max EPS beat(2)4.42%
EPS beat(4)3
Avg EPS beat(4)5.73%
Min EPS beat(4)-17.26%
Max EPS beat(4)23.22%
EPS beat(8)5
Avg EPS beat(8)-3.43%
EPS beat(12)8
Avg EPS beat(12)0.38%
EPS beat(16)12
Avg EPS beat(16)2.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-3.42%
Max Revenue beat(2)0.05%
Revenue beat(4)1
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-4%
Max Revenue beat(4)0.05%
Revenue beat(8)1
Avg Revenue beat(8)-3.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)8
Avg Revenue beat(16)-0.91%
PT rev (1m)-0.32%
PT rev (3m)-14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-1.28%
Valuation
Industry RankSector Rank
PE 5.49
Fwd PE 4.97
P/S 0.49
P/FCF 4.33
P/OCF 2.88
P/B 0.75
P/tB N/A
EV/EBITDA 5.93
EPS(TTM)4.26
EY18.21%
EPS(NY)4.71
Fwd EY20.13%
FCF(TTM)5.4
FCFY23.07%
OCF(TTM)8.12
OCFY34.71%
SpS47.58
BVpS31.11
TBVpS-20.04
PEG (NY)0.52
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -2.88%
ROCE 2.42%
ROIC 2.16%
ROICexc 2.34%
ROICexgc 6.99%
OM 4.24%
PM (TTM) N/A
GM 57.14%
FCFM 11.35%
ROA(3y)0.54%
ROA(5y)-0.82%
ROE(3y)1.6%
ROE(5y)-4.19%
ROIC(3y)7.78%
ROIC(5y)N/A
ROICexc(3y)8.73%
ROICexc(5y)N/A
ROICexgc(3y)39.42%
ROICexgc(5y)N/A
ROCE(3y)8.72%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5Y0.14%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 7.76
Debt/EBITDA 3.88
Cap/Depr 35.8%
Cap/Sales 5.72%
Interest Coverage 1.07
Cash Conversion 84.37%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.81
Altman-Z 0.9
F-Score6
WACC5.94%
ROIC/WACC0.36
Cap/Depr(3y)52.75%
Cap/Depr(5y)45.17%
Cap/Sales(3y)5.84%
Cap/Sales(5y)5.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.41%
EPS 3Y-13.17%
EPS 5Y-8.43%
EPS Q2Q%-85.85%
EPS Next Y10.52%
EPS Next 2Y9.08%
EPS Next 3Y6.35%
EPS Next 5Y5.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.39%
Revenue Next Year0.12%
Revenue Next 2Y0.98%
Revenue Next 3Y1.38%
Revenue Next 5Y1.43%
EBIT growth 1Y1468.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.33%
EBIT Next 3Y8.68%
EBIT Next 5Y4.65%
FCF growth 1Y23.15%
FCF growth 3Y-1.53%
FCF growth 5Y-14.98%
OCF growth 1Y12.83%
OCF growth 3Y1.48%
OCF growth 5Y-8.36%